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Background: Effective treatment of locomotor dysfunction in Parkinson disease (PD) is essential, as gait difficulty is
an early and major contributor to disability. Exercise is recommended as an adjunct to traditional treatments for
improving gait, balance, and quality of life. Among the exercise approaches known to improve walking, tango
and treadmill training have recently emerged as two promising therapies for improving gait, disease severity and
quality of life, yet these two interventions have not been directly compared to each other. Prior studies have been
helpful in identifying interventions effective in improving gait function, but have done little to elucidate the neural
mechanisms underlying functional improvements. The primary objective of the proposed work is to compare
the effects of three community-based exercise programs, tango, treadmill training and stretching, on locomotor
function in individuals with PD. In addition, we aim to determine whether and how these interventions alter
functional connectivity of locomotor control networks in the brain.
Methods/Design: One hundred and twenty right-handed individuals with idiopathic PD who are at least 30 years
of age will be assigned in successive waves to one of three community-based exercise groups: tango dancing,
treadmill training or stretching (control). Each group will receive three months of exercise training with twice
weekly one-hour group classes. Each participant will be evaluated at three time points: pre-intervention (baseline),
post-intervention (3 months), and follow-up (6 months). All evaluations will include assessment of gait, balance,
disease severity, and quality of life. Baseline and post-intervention evaluations will also include task-based functional
magnetic resonance imaging (fMRI) and resting state functional connectivity MRI. All MRI and behavioral measures
will be conducted with participants OFF anti-Parkinson medication, with behavioral measures also assessed ON
medication.
Discussion: This study will provide important insights regarding the effects of different modes of exercise on
locomotor function in PD. The protocol is innovative because it: 1) uses group exercise approaches for all
conditions including treadmill training, 2) directly compares tango to treadmill training and stretching, 3) tests
participants OFF medication, and 4) utilizes two distinct neuroimaging approaches to explore mechanisms of the
effects of exercise on the brain.
Trial registration: ClinicalTrials.gov NCT01768832.
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Parkinson disease (PD) is the second most common
neurodegenerative disorder in the United States, affecting
1–1.5 million Americans [1]. Numerous non-motor and
motor symptoms including gait dysfunction characterize
PD. Gait dysfunction frequently causes substantial and
early difficulties in people with PD and may represent the
leading edge of disability [2]. Reduced speed and stride
length contribute to gait dysfunction [3,4]. These gait diffi-
culties not only affect forward walking, but also impair
backward walking, during which gait speed and stride
length are reduced to a greater degree relative to healthy
controls [5,6]. While pharmacological and surgical ap-
proaches to the management of PD can help to partially
alleviate some gait problems, they do not completely ad-
dress the issue, indicating a need for additional and
complementary approaches to the treatment of gait in
PD. Numerous studies demonstrated the effectiveness
of exercise as a complementary treatment for improving
gait function in PD. Among the exercise approaches
known to improve walking function, tango and tread-
mill training have recently emerged as two promising
therapies for improving gait while also reducing disease
severity and improving quality of life (for reviews see
[7-9]), yet tango and treadmill training have not been dir-
ectly compared to each other. Furthermore, the neural
mechanisms underlying these interventions remains to be
elucidated. Neuroimaging may be a means to investigate
these underlying mechanisms
Investigations of gait-related dysfunction in humans is
particularly challenging. Neuroimaging may provide a
means to investigate the role of exercise interventions in
individuals with PD, but this approach presents a chal-
lenge due to difficulties collecting neuroimaging data dur-
ing a gait task. Alternatively, imaging during an imagined
walking task can provide insights into underlying brain
mechanisms related to gait in healthy controls [10,11] and
those with neurological disorders [12,13]. This imagined
task activates networks involved with actual walking [10].
Another neuroimaging method that can be used to inves-
tigate brain networks related to locomotion networks uses
resting state functional connectivity magnetic resonance
imaging (rs-fcMRI), which assesses brain activity at rest
and therefore eliminates the need to evoke actual or imag-
ined locomotor behaviors. In contrast to task-related acti-
vations, rs-fcMRI focuses on spontaneous fluctuations in
the blood oxygen level dependent (BOLD) signal at rest;
regional fluctuations in these signals correlate with
functionally related regions. Thus, rs-fcMRI identifies
related networks within the resting state BOLD data, re-
vealing functionally related resting state networks that
can be quantified. [14]. These rs-fcMRI methods iden-
tify common networks in healthy individuals and can
detectchanges in these networks related to a variety ofneurological disorders\(for review see [15]). Resting state-
functional connectivity MRI holds great promise as a po-
tential biomarker for progression of disease, elucidating
compensatory mechanisms associated with disease pro-
cesses, informing targeting of neurosurgical treatments,
and investigating new treatment strategies. rs-fcMRI has
not yet been applied to study the effects of exercise on
functional brain networks in humans with PD.
To investigate and compare the mechanisms under-
lying various PD exercise training approaches, we plan
to conduct a 5-year, prospective, randomized, blinded
study of a cohort of persons with PD. The main object-
ive of this study will be to determine the effects of tango,
treadmill training, and stretching (control) exercise on
locomotor function and other aspects of PD. Addition-
ally, we aim to determine how exercise impacts activity
of specific brain regions and networks involved in loco-
motion using task-based and rs-fcMRI.
We hypothesize that tango and treadmill training will
show similar improvement with forward walking per-
formance, but only tango will improve backward walking
performance. Tango and treadmill training will similarly
improve disease severity. Additionally, tango will result in
large improvements in balance and quality of life compared
to treadmill training and stretching. With neuroimaging,
we hypothesize that a differential BOLD signal increase will
be observed in regions of interest during imagined forward
walking following tango and treadmill training, and during
imagined backward walking following tango only. Add-
itionally, following tango and treadmill training, rs-fcMRI
coherence in the motor network will be increased and will
correlate with improvements in gait performance. No sig-
nificant rs-fcMRI or task-related BOLD signal changes will
occur in the stretching group.
Methods
Study design
This project is a 5-year, prospective, randomized controlled
trial (Figure 1). Participant will be assigned to one of three
different exercise groups (tango, treadmill, stretching). As-
sessments will be conducted at three time points: pre-
intervention (baseline), post-intervention (3 months), and
follow-up (6 months). The primary variable of interest is
gait velocity in both forward and backward walking. Sec-
ondary variables include motor sign severity (Movement
Disorders Society-Unified Parkinson Disease Rating Scale-
subsection III), balance (mini-Balance Evaluation Systems
Test (mini-BESTest)), and quality of life (Parkinson Disease
Questionnaire-39). All evaluations will be administered by
a research physical therapist. The MDS-UPDRS-III and
mini-BESTest measures will be video recorded and eval-
uated separately by a Movement Disorders neurologist,
who will be blinded to the group assignment, assessment
time point, and medication status of each participant.
Figure 1 Diagram showing the flow of participants through the study.
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collected at all evaluations so that changes in medication
over the course of the study can be noted and controlled
for during statistical analyses. Participants will also
undergo separate task-based and rs-fcMRI to explore
the effects of these exercise interventions on brain activ-
ity. We will focus on locomotor network activity within
specific regions of interest including the premotor area,
supplementary motor area, primary somatosensory cortex,
putamen, and cerebellum. We will also correlate changes
in connectivity with changes in motor performance. This
study is approved by the Human Research Protection
Office at the Washington University School of Medicine
and meets all guidelines associated with human subject re-
search. All participants will provide written and informed
consent prior to participation in this study.
Participant selection
One hundred and twenty right-handed participants with
idiopathic PD who are at least 30 years of age will be
recruited through the Washington University School of
Medicine’s Movement Disorders Center, Volunteers for
Health database, and the Greater St. Louis Area Chapter
of American Parkinson Disease Association. Participants
must be diagnosed with clinically defined “definite PD”,
as previously described by Racette et al. [16] based upon
established criteria [17-19]. Each participant must: 1) have
clear benefit from levodopa, 2) be classified between
Hoehn & Yahr stages I-IV, and 3) be able to walk inde-
pendently with or without an assistive device for at least
three meters. Participants will be randomly recruited fromour community and assigned to interventions in blocks of
10–16 participants per wave. Three or four waves of each
exercise group will be conducted as needed to achieve the
desired sample size.Procedures
All physical evaluations and MRI scans will be conducted
OFF medication, i.e. after a minimum 12-hour withdrawal
of all anti-Parkinson medications. Evaluations for a single
individual will always take place at the same time of day
for all visits. MRI scans will also take place at the same
time of day but on a separate date as close as possible to
the associated date of evaluation. During the physical
evaluation, participants will be evaluated first during the
OFF medication period, given their normal dosage of anti-
Parkinson medication, and then re-evaluated during the
ON medication phase after a 45–60 minute waiting
period to allow the medication to take effect. OFF medi-
cation measures will provide more accurate information
about disease severity and effects of the disease on phys-
ical function without the confound of medication mask-
ing some symptoms, while ON medication measures
will provide information about participant function in
their everyday medicated state. During evaluations, par-
ticipants will be allowed to rest as often as needed. Mea-
sures to be collected at each physical evaluation are
included in Table 1. At the pre- and post-intervention
time points, each participant will undergo task-based
fMRI and rs-fcMRI scans as detailed below in MRI Proto-
col. Demographic information will be collected at baseline
Table 1 Outcome measures administered at each
evaluation
Outcome measure Reliability/Validity references
Spatiotemporal Features of Gait Nelson et al. 2002 [20]
MDS-UPDRS-3 Goetz et al. 2008 [21]
Mini-BESTest Leddy et al. 2011 [22]
PDQ-39 Jenkinson et al. 1997 [23]
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ation of PD symptoms.MRI protocol
MRI data will be collected on a Siemens 3.0 T TrioTim
scanner located in Mallinckrodt Institute of Radiology
Neuroimaging Laboratory at the Washington University
School of Medicine.
During each visit participants will have 2 structural
scans: a T1-weighted (T1W) sagittal, magnetization pre-
pared rapid acquisition with gradient echo (MP-RAGE,
Repetition Time (TR) =2400 ms, TI = 1000 ms, Echo Time
(TE) = 3.16 ms, Flip Angle (FA) = 8°, 0.9 mm3 voxels,
8:09 min) and a T2-weighted (T2W) fast spin echo
(TR = 3200 ms, TE = 455 ms, 1.0 mm3 voxels, 4:43 min).
At each session, gradient and shim coil currents will be
adjusted to correct for spatial inhomogeneities using the
scanner’s multi-axis-projection shim program. A midsagit-
tal scout T1W spin-echo pulse sequence will be used for
positioning. Resting state-functional connectivity MRI
data will be acquired via two T2*-weighted gradient echo
multislice BOLD sensitized fMRI scans (Echo Planar Im-
aging (EPI); TR = 2200 ms, TE =3 ms, 4.0 mm3 voxels,
7:30-per scan, 200 frames). BOLD scans will capture 36
slices covering the brain and the cerebellum. During the
rs-fcMRI scan, the participant is instructed to remain alert
but relaxed with their eyes closed. Participants are moni-
tored via an MRI-compatible eye tracker during data col-
lection to ensure that their eyes remain closed throughout
each session. Resting state data will be acquired prior to
any imagined walking scans. The imagined walking com-
ponent will consist of an additional two T2*-weighted
gradient echo multislice BOLD sensitized fMRI scans
(EPI; TR = 2200 ms, TE = 3 ms, 4.0 mm3 voxels, 7:30-per
scan, 200 frames), acquired while the participant views a
cue or null condition on a mirror mounted to the headFigure 2 Illustration of boxcar design for imagined walking tasks.coil. Cues will be generated via a custom made ePrime
program using the design shown in Figure 2.
To ensure adherence and maximize vividness of the
imagined tasks, we will utilize a variable distance cued
gait task. This method has been described previously [24].
In brief, prior to beginning the scanning sessions, each in-
dividual will practice performing and imagining three tasks:
walking forward, walking backward, and quiet standing.
Forward and backward walking tasks will be completed at
four and eight meters. Following each practiced gait task,
the participant will be seated and given a stopwatch. They
will then be asked to close their eyes and visualize them-
selves standing on the start-line. When they are able to
clearly see them self in position they will press the stop-
watch button and beginning imagining themselves walking
the indicated distance from the first person perspective.
With their eyes closed they will continue to imagine them-
selves walking down the hall until they cross the finish-line
for the specified distance. At this point they should press
the stopwatch button a second time to stop the timer.
Once in the MRI scanner, participants will be instructed
to imagine walking forward or backward for four or
eight meters. In addition to the walking tasks, partici-
pants will also imagine themselves standing quietly or
performing a “rest”. As described previously [24,25], imag-
ined stand trials will be collected during a separate acqui-
sition. An fMRI compatible response pad (Mag Design
and Engineering, Redwood City, CA) will be used to
record the task initiation and termination times, thus
allowing for assessment of task completion intervals. Any
participant who does not appropriately scale their re-
sponse to the change in task interval will be excluded
from further analyses. Furthermore, each participant will
be directly observed during each scan to check for any
spurious movements of the limbs or body. If seen, then
this BOLD run will be stopped and the person reminded
to try to hold still.
Processing of fMRI BOLD data for the imagined walking
conditions will be completed in Brain Voyager QX (Brain
Innovation, Maastricht, The Netherlands) and using cus-
tom Matlab scripts (Mathworks, Inc., Natick, MA). To
facilitate comparison of anatomical locations across all
participants, transformation of T1 weighted scans into
Talairach space will be completed prior to functional data
alignment [26]. Blood oxygenated level dependent data
will undergo 3D motion correction and alignment to the
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Comparisons between stimuli will be done using an eight
predictor general linear model (GLM). The hemodynamic
response function will be accounted for within the GLM
model.
Processing of BOLD rs-fcMRI data will follow the
methods of Fox et al. [27] and include compensation for
systematic, slice-dependent time shifts, elimination of
systematic odd-even slice intensity differences due to
interleaved acquisition, rigid-body correction for head
motion within and across runs, and normalization of the
signal intensity across each run (skipping the first two
frames) to obtain a whole-brain mode value of 1000. Atlas
transformation will be achieved by composition of affine
transforms connecting the first functional volume (aver-
aged over all fMRI runs after cross-run realignment) with
the T2W and T1W structural images. Common mode
image registration (to correct for head motion within and
across fMRI runs and affine warping of T1W images to
our atlas image) will be done using standard algorithms.
Cross-modal registration (e.g., T2W to T1W images) will
be performed using vector gradient measure maximization.
Linear trends across runs will be removed voxel-wise, and
the data will be low-passed filtered retaining frequencies
below 0.1Hz. Several sources of spurious variance will be
removed by regression of the following nuisance variables
and their first derivatives: (1) the 6 parameters resulting
from rigid body correction for head motion; (2) a signal
from a ventricular region of interest (ROI); (3) and a signal
from a white matter ROI. BOLD data from each rs-fcMRI
run will be resampled to 2-mm cubic voxels in atlas space
for final analyses. Rigorous QA measures will be applied
to minimize the impact of motion artifacts and move-
ment confound. fMRI runs in which head motion ex-
ceeds 0.6 mm rms or the voxel-wise temporal standard
deviation averaged over the brain (after full preprocess-
ing) exceeds 0.5% will be excluded. Volumes with large
changes in signal intensity (DVARS > 0.5%) will be ex-
cluded. Participants with more than 15% volumes re-
moved also will be excluded [28].
Intervention groups
All groups will participate in community-based group
exercise, attending one-hour sessions twice per week for
twelve weeks. Each class will include a brief warm up
and cool down with 45 minutes of the hour devoted to
the specific exercise.
Tango
Argentine tango classes will be modeled on those from
previous studies, as described in Hackney & Earhart
[29,30]. Participants in the Tango class will dance both
leading and following roles to ensure that everyone
spends time moving forward and backward. Participantswill also change partners frequently to ensure they get
experience dancing with many different partners. Tango
partners will be individuals without PD and will include
spouses and caregivers of those with PD as well as healthy
volunteers. A syllabus and standardized musical selections
will be utilized to ensure that all waves of the tango class
are consistent.
Treadmill
Participants in the treadmill class will walk at their self-
selected comfortable over-ground walking pace in order
to exercise at intensities comparable to the tango class.
Furthermore, recent evidence suggests that training at
preferred speed for longer durations is more effective in
enhancing gait than training at higher intensity for shorter
blocks of time [31,32]. Over ground walking speed will be
reassessed every week and the treadmill speed will be ad-
justed accordingly to ensure it matches over ground walk-
ing speed. To match the social aspect of the tango, where
one interacts with a partner, treadmills will be arranged in
clusters so that each individual has a walking partner with
whom they can interact with during training. As with
tango, people will be required to change partners fre-
quently throughout a session. Treadmill classes will use
the same musical selections as the tango classes.
Stretching
Participants in the stretching class will be instructed by
a trained physical therapist on stretching and flexibility
exercises taken from the Be Active and Fitness Counts
programs [33,34]. As with the other groups, each indi-
vidual will be assigned a partner and will switch part-
ners regularly during each session. Stretching classes




Spatiotemporal features of gait will be measured at each
evaluation using a five-meter instrumented, computer-
ized walkway (GAITRite, CIR Systems, Inc., Havertown,
PA). The primary variable of interest from the GAITRite
will be forward gait velocity. Additional variables of inter-
est include stride length, stride length variability (CV), and
gait asymmetry ([35,36]). Participants will perform three
trials of each of the following walking conditions: 1) for-
ward, 2) backward, 3) dual-task, and 4) fast as possible.
Results from the three trials of each walking task will be
averaged. For the dual-task condition, participants will be
instructed to walk at their self-selected pace while com-
pleting a phonemic naming task. For the fast as possible
condition, participants will be instructed to walk as
quickly and safely as possible without running.
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Motor sign severity will be measured at each evaluation
using the MDS-UPDRS-III questionnaire. This section
consists of 18 items pertaining to the cardinal motor
features of PD, with each item rated on a 5 point (0–4)
ordinal scale. Higher scores indicate greater PD motor
sign severity.
Balance will be measured at each evaluation using the
Mini-Balance Evaluation Systems Test (Mini-BEST). This
test includes 14 items addressing four balance systems:
anticipatory postural adjustments, reactive postural con-
trol, sensory orientation, and dynamic gait stability. Each
item is rated on a 3 point (0–2) ordinal scale. Lower scores
indicate greater balance impairment.
Quality of life will be measured at each evaluation
using the Parkinson Disease Questionnaire (PDQ-39), a
39-item self-report questionnaire, which assesses PD-
specific health related quality over the previous month.
Higher scores indicate worse quality of life.
Endurance will be measured at each evaluation using
the 6-Minute Walk Test (6MWT). Participants will be
instructed to walk, at a self-selected speed, as far a dis-
tance as possible over the span of 6 minutes. Participants
will be allowed to use assistive devices but must stay
consistent from evaluation to evaluation.
BOLD activity in imagined walking tasks
Region of Interest (ROI) beta weight values for the gen-
eral linear model contrasts (Forward vs. Rest and Back-
ward vs. Rest) will be used to compare changes in BOLD
signal values during imagined gait at the pre-test and
post-test time points.
Functional connectivity
The strength of correlations between brain regions will
be used to assess changes in rs-fcMRI from pre-test to
post-test.
Statistical analysis
We will employ a repeated measure (RM) ANOVA with
group (tango, treadmill, and stretching) and time (pre-
intervention, post-intervention, and follow-up) as factors
to determine whether and how these interventions im-
pact gait velocity. Similar analyses will also be performed
for secondary variables of interest, including the MDS-
UPDRS-III, Mini-BESTest, and PDQ-39. To analyze fMRI
BOLD data, we will apply random effects (RFX) general
linear model analysis using forward, backward and stand-
ing imagined tasks as individual predictors. A false discov-
ery rate (FDR) correction of Q = 0.01 will be used to
compensate for multiple comparisons. Significant clusters
of voxels will be identified for pre- and post-intervention
conditions. Additionally, the three groups will be com-
pared to each other in the post-intervention conditionusing RFX ANCOVA. For analysis of rs-fcMRI data we
will use an independent component analysis (ICA) to
examine the strength of the correlation coefficients for
anatomical regions identified as part of the locomotor
control network, which include the premotor area, supple-
mentary motor area, primary somatosensory cortex, puta-
men, and cerebellum. The strength of these correlations
before and after the intervention will be compared via
two-tailed RM ANOVAs with group and time as factors.
Finally, we will correlate BOLD signal changes during the
imagined walking tasks and changes in connectivity
with changes in motor performance using Pearson or
Spearman linear correlations as appropriate. The a-priori
alpha level for analyses is set at 0.05.
Power analysis
We used PASS software (NCSS, LLC, Kaysville, UT) to
calculate statistical power based on preliminary data.
Our primary variable of interest for behavioral data is
gait velocity. Average forward gait velocity was 1.2 ±
0.1 m/s and average backward gait velocity was 0.6 ± 0.1
in a sample of 60 individuals with PD (H&Y = 2.4 ± 0.2)
tested OFF medication in our laboratory over the past
year for a different study. The current study has been
powered to be able to detect differences of 1 standard de-
viation, or 0.1 m/s, which is equivalent to an effect size of
0.4. Changes of 0.1 m/s or more in gait velocity have been
reported previously following both tango [29,30,37] and
treadmill training [9,38-40]. With an effect size of 0.4, 27
participants per group will provide 89% power to detect
differences between or within groups using two-tailed
tests at a significance level of 0.05. Based upon our previ-
ous data, this sample size is also more than sufficient to
adequately power our secondary variables (MDS-UPDRS-
III, Mini-BESTest, and PDQ-39).
Sample sizes for imaging portions of this study were cal-
culated based upon preliminary data from our lab and
sources in the literature. To analyze fMRI BOLD data, our
preliminary data from control participants before and after
a single session of treadmill training indicate an effect size
of 0.91 for change in beta weights (pre = −0.094 ± 0.111,
post = 0.418 ± 0.116, Earhart laboratory unpublished data)
using the cerebellum as an exemplar region during imag-
ined forward walking. We recognize that responses in
those with PD may be less pronounced than in controls
and as such have used a conservative effect size of 0.45,
half of that observed in controls, for our power calcula-
tion. Our preliminary imagined task-based fMRI BOLD
data from people with PD (n = 8) indicate a beta weight
of −0.075 ± 0.097, which is comparable to the value ob-
tained from young controls at baseline. Utilizing the
data from the sample with PD and an estimated effect
size of 0.45, 18 subjects per groups will provide 80%
power to detect differences between groups and 88%
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findings of differential BOLD signal changes have been
localized to specific brain regions in PD populations
during similar imagined walking MRI paradigms with a
total of 12 PD participants per group [41], further sup-
porting that our proposed sample size is adequate. Utiliz-
ing rs-fcMRI to determine correlations between regions in
the locomotor control network, we have powered the
study to enable detection of differences in correlation co-
efficients of 0.1 (mean correlation = 1.0, SD = 0.1, p = 0.05,
effect size = 0.44, per data from Wu et al. [42] and our
own preliminary data). We will have 80% power to detect
between group differences and 88% power to detect within
group differences with 18 subjects per group.
Based upon our previous intervention studies [30], we
anticipate an attrition rate of approximately 15-20% due
to dropouts or failure to complete the required minimum
of 85% of classes. We also expect MRI-related exclusions
due to head or body motion in roughly 30% of tested indi-
viduals. As such, we will recruit 40 subjects per group to
account for attrition and data loss due to head or body
motion and still obtain the needed final sample sizes for
each aim.
Discussion
This study is innovative in several respects with two
novel aspects that will potentially lay the foundation for
many future studies. First, this will be the first study to
perform a direct, head-to-head comparison of tango and
treadmill training. Currently, it is unclear which of the
interventions provides the largest improvement in gait,
or which of these interventions may be better for improv-
ing PD motor symptoms, balance, and quality of life. This
intervention study will address these questions and could
lead to studies that combine these two treatment ap-
proaches into an exercise program that could be more ef-
fective than either intervention on its own. Second, the
use of two distinct neuroimaging techniques, fMRI BOLD
and rs-fcMRI, before and after intervention, will allow us
to explore neurological mechanisms underlying changes
in physical performance due to exercise training. The im-
aging techniques proposed herein will also lay the ground-
work for us to answer many other questions regarding
locomotor control mechanisms in PD.
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